KA
Kintegral Advisory’s Boston Scientific BSX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.99M | Sell |
55,801
-85
| -0.2% | -$9.13K | 0.55% | 49 |
|
|
2025
Q1 | $5.64M | Sell |
55,886
-187
| -0.3% | -$18.9K | 0.57% | 46 |
|
|
2024
Q4 | $5.01M | Sell |
56,073
-2,613
| -4% | -$233K | 0.47% | 57 |
|
|
2024
Q3 | $4.92M | Sell |
58,686
-768
| -1% | -$64.4K | 0.45% | 67 |
|
|
2024
Q2 | $4.58M | Buy |
59,454
+48,820
| +459% | +$3.76M | 0.44% | 64 |
|
|
2024
Q1 | $728K | Sell |
10,634
-33
| -0.3% | -$2.26K | 0.07% | 189 |
|
|
2023
Q4 | $617K | Sell |
10,667
-68
| -0.6% | -$3.93K | 0.07% | 199 |
|
|
2023
Q3 | $567K | Sell |
10,735
-6
| -0.1% | -$317 | 0.07% | 195 |
|
|
2023
Q2 | $581K | Hold |
10,741
| – | – | 0.07% | 199 |
|
|
2023
Q1 | $537K | Buy |
+10,741
| New | +$537K | 0.07% | 197 |
|
|
2022
Q4 | – | Sell |
-16,618
| Closed | -$644K | – | 267 |
|
|
2022
Q3 | $644K | Hold |
16,618
| – | – | 0.09% | 181 |
|
|
2022
Q2 | $619K | Buy |
16,618
+352
| +2% | +$13.1K | 0.08% | 194 |
|
|
2022
Q1 | $720K | Buy |
16,266
+364
| +2% | +$16.1K | 0.08% | 191 |
|
|
2021
Q4 | $676K | Hold |
15,902
| – | – | 0.07% | 196 |
|
|
2021
Q3 | $690K | Hold |
15,902
| – | – | 0.08% | 192 |
|
|
2021
Q2 | $680K | Hold |
15,902
| – | – | 0.08% | 199 |
|
|
2021
Q1 | $615K | Hold |
15,902
| – | – | 0.08% | 206 |
|
|
2020
Q4 | $572K | Hold |
15,902
| – | – | 0.08% | 200 |
|
|
2020
Q3 | $608K | Sell |
15,902
-512
| -3% | -$19.6K | 0.09% | 179 |
|
|
2020
Q2 | $576K | Hold |
16,414
| – | – | 0.09% | 186 |
|
|
2020
Q1 | $536K | Buy |
16,414
+1,836
| +13% | +$60K | 0.1% | 169 |
|
|
2019
Q4 | $659K | Hold |
14,578
| – | – | 0.12% | 162 |
|
|
2019
Q3 | $593K | Hold |
14,578
| – | – | 0.12% | 165 |
|
|
2019
Q2 | $627K | Hold |
14,578
| – | – | 0.13% | 160 |
|
|
2019
Q1 | $560K | Buy |
14,578
+674
| +5% | +$25.9K | 0.12% | 168 |
|
|
2018
Q4 | $491K | Buy |
+13,904
| New | +$491K | 0.15% | 132 |
|